Multidimensional 3-Month Follow-Up of Severe COVID-19: Airways beyond the Parenchyma in Symptomatic Patients

SARS-CoV-2 may lead to a large spectrum of respiratory manifestations, including pulmonary sequelae. We conducted a single-center longitudinal study of survivors from severe COVID-19 cases who underwent a chest CT during hospitalization (CTH). Three months after being discharged, these patients were evaluated by a clinical examination, pulmonary function tests and a chest-CT scan (CTFU). Sixty-two patients were enrolled. At follow-up, 27% complained of exertional dyspnoea and 12% of cough. Dyspnoeic patients had a lower forced expiratory flow (FEF)25–75 (p = 0.015), while a CT scan (p = 0.016 showed that patients with cough had a higher extent of bronchiectasis. Lung volumes and diffusion of carbon monoxide (DLCO) at follow-up were lower in patients who had been invasively ventilated, which correlated inversely with the length of hospitalization and ground-glass extension at CTH. At follow-up, 14.5% of patients had a complete radiological resolution, while 85.5% presented persistence of ground-glass opacities, and 46.7% showed fibrotic-like alterations. Residual ground-glass at CTFU was related to the length of hospitalization (r = 0.48; p = 0.0002) and to the need for mechanical ventilation or high flow oxygen (p = 0.01) during the acute phase. In conclusion, although patients at three months from discharge showed functional impairment and radiological abnormalities, which correlated with a prolonged hospital stay and need for mechanical ventilation, the persistence of respiratory symptoms was related not to parenchymal but rather to airway sequelae.

[1]  F. Kakamad,et al.  Post COVID-19 pulmonary fibrosis; a meta-analysis study , 2022, Annals of Medicine and Surgery.

[2]  T. Franquet,et al.  Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT , 2022, European Radiology.

[3]  S. Stanojevic,et al.  ERS/ATS technical standard on interpretive strategies for routine lung function tests , 2021, European Respiratory Journal.

[4]  P. Spagnolo,et al.  Characteristics and Prognostic Factors of Pulmonary Fibrosis After COVID-19 Pneumonia , 2022, Frontiers in Medicine.

[5]  Y. Wi,et al.  Residual Lung Lesions at 1-year CT after COVID-19 , 2021, Radiology.

[6]  M. Cova,et al.  Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy , 2021, Journal of clinical medicine.

[7]  Mark G. Jones,et al.  3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study , 2021, The Lancet Respiratory Medicine.

[8]  E. Coche,et al.  Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae , 2021, Respiratory Medicine.

[9]  J. Sohn,et al.  Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study , 2021, Therapeutic advances in respiratory disease.

[10]  H. Ghanaati,et al.  Clinical and chest CT features as a predictive tool for COVID-19 clinical progress: introducing a novel semi-quantitative scoring system , 2021, European Radiology.

[11]  Hui Dai,et al.  Inspiratory and Expiratory Chest High-Resolution CT: Small-Airway Disease Evaluation in Patients with COVID-19. , 2021, Current medical imaging.

[12]  L. Ebner,et al.  Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study , 2021, European Respiratory Journal.

[13]  Guohui Fan,et al.  RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.

[14]  M. Garg,et al.  Sequelae of COVID-19 pneumonia: Is it correct to label everything as post-COVID lung fibrosis? , 2021, Journal of postgraduate medicine.

[15]  F. Kronenberg,et al.  Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial , 2020, European Respiratory Journal.

[16]  M. Garg,et al.  Diagnostic accuracy of CT and radiographic findings for novel coronavirus 2019 pneumonia: Systematic review and meta-analysis , 2020, Clinical Imaging.

[17]  Yanfeng Gao,et al.  Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery , 2020, EClinicalMedicine.

[18]  Hong Yang,et al.  Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge , 2020, Journal of X-ray science and technology.

[19]  Edward Y Lee,et al.  Follow-up chest radiographic findings in patients with MERS-CoV after recovery , 2017, Indian Journal of Radiology and Imaging.

[20]  N. Müller,et al.  Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.

[21]  J. Sung,et al.  The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors , 2005, Chest.

[22]  J. Sung,et al.  Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors , 2005, Thorax.

[23]  P. Molina,et al.  High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. , 2004, The Journal of pediatrics.